Genetic testing can feel different from other medical tests because the results may affect more than one person. A brain MRI, cognitive screen, or blood test usually gives information about the person being tested. A genetic test may also raise questions for children, siblings, parents, and other relatives.
Genetic counseling helps slow the decision down in a useful way. Before testing, a counselor or genetics-informed clinician explains what the test can show, what it cannot show, who in the family may be affected by the result, and whether testing is medically useful in the first place. This is especially important when the concern involves early-onset dementia, a strong family history of Alzheimer’s disease or frontotemporal dementia, direct-to-consumer genetic results, or APOE testing before certain Alzheimer’s treatment decisions.
Table of Contents
- Why Genetic Counseling Matters
- When Testing Is Considered
- What Happens Before Testing
- Types of Genetic Results
- Family, Privacy, and Insurance Issues
- How Testing Fits the Dementia Workup
- Questions to Ask Before Deciding
Why Genetic Counseling Matters
Genetic counseling helps determine whether a genetic test is appropriate, which test is most useful, and how to prepare for possible results. It is not just an explanation of lab forms; it is a structured conversation about medical value, emotional readiness, family implications, and consent.
Not every person with memory loss, brain fog, mood symptoms, or dementia symptoms needs genetic testing. Most dementia is not caused by a single inherited mutation. Alzheimer’s disease, for example, is usually multifactorial, meaning age, biology, cardiovascular health, lifestyle, environment, and many genes can all contribute. A person can have a family history of dementia without having a single-gene disorder.
Counseling is most useful when the question is more specific: Could this condition be inherited in a strong, predictable way? Would a result change diagnosis, treatment eligibility, family planning, clinical trial options, or testing for relatives? Would the result create uncertainty without changing care?
A genetics professional may also help separate different kinds of testing. Diagnostic genetic testing looks for a genetic cause in someone who already has symptoms. Predictive or presymptomatic testing looks for a known family mutation in someone who does not yet have symptoms. Risk testing, such as APOE testing, estimates risk or treatment-related risk but usually does not confirm that someone will or will not develop Alzheimer’s disease.
That distinction matters. A positive result in a high-penetrance dementia gene can have major implications for relatives. A positive APOE result, by contrast, may increase risk but does not diagnose Alzheimer’s disease. A negative result may reduce the likelihood of one specific inherited cause, yet it often cannot remove all future risk.
Genetic counseling is also different from general education about genetic testing for brain and mental health conditions. In counseling, the discussion is personalized to the person’s symptoms, family history, test options, and goals. A careful counselor may even recommend not testing yet, testing an affected relative first, or completing the regular neurological workup before ordering DNA testing.
This does not mean genetic testing is something to fear. It means the decision deserves the same care as the information it may reveal. A well-done counseling visit should leave a person with a clearer sense of choice, not pressure to proceed.
When Testing Is Considered
Genetic testing is usually considered when the pattern of symptoms, age of onset, or family history suggests a possible inherited brain or dementia condition. It may also come up when APOE testing is being discussed for Alzheimer’s risk information or treatment planning.
A common reason for referral is dementia that begins unusually early, often before age 65 and especially before age 60. Early-onset symptoms do not automatically mean a person has an inherited dementia, but they raise the likelihood enough that a specialist may consider genetic evaluation. A strong family history also matters, especially when multiple relatives across generations had similar symptoms, early dementia, movement changes, psychiatric changes, or a known genetic result.
Genetic counseling may be discussed in several situations:
| Situation | Why counseling helps |
|---|---|
| Dementia symptoms before age 65 | Early onset can increase concern for a monogenic or hereditary form, especially with family history. |
| Several relatives with dementia or related neurological symptoms | A counselor can look for inheritance patterns and identify the best person in the family to test first. |
| Possible frontotemporal dementia | Some forms are linked to genes such as C9orf72, GRN, and MAPT, and results may affect relatives. |
| Known familial mutation | Relatives may consider predictive testing, which requires careful consent and emotional preparation. |
| APOE testing before Alzheimer’s treatment decisions | APOE status may inform risk discussions for certain anti-amyloid therapies, but it is not a simple diagnostic answer. |
| Direct-to-consumer genetic results | Clinical confirmation and correct interpretation may be needed before making medical decisions. |
In Alzheimer’s disease, the best-known deterministic genes are APP, PSEN1, and PSEN2. Pathogenic variants in these genes are uncommon but can cause autosomal dominant early-onset Alzheimer’s disease, meaning each child of a person with the variant may have a 50% chance of inheriting it. This is very different from more common Alzheimer’s risk genes. A counselor may explain why APOE genetic testing for Alzheimer’s risk has different limits from testing for a known disease-causing variant.
Frontotemporal dementia has its own genetic considerations. Behavioral changes, language changes, motor neuron disease, parkinsonism, or symptoms beginning in midlife may prompt discussion of frontotemporal dementia testing. In some families, the same genetic variant can appear as dementia, ALS-like symptoms, psychiatric symptoms, or movement problems, which is why the family history may need to include more than memory loss.
Testing may also be considered for other hereditary brain conditions, such as Huntington disease, inherited prion disease, CADASIL, some leukodystrophies, or rare metabolic and movement disorders. The exact test depends on the clinical picture. A broad panel may be useful in one case, while a single-gene test is more appropriate in another.
What Happens Before Testing
Before testing, the counselor usually reviews the medical question, family history, possible test choices, and what each result could mean. The goal is to make sure the test matches the reason for testing and that consent is truly informed.
The first part often feels like a detailed interview. The counselor may ask about the person’s symptoms, age when symptoms began, prior evaluations, medications, brain imaging, cognitive testing, and any diagnoses already given. If dementia is suspected, the counselor may ask whether the person being tested can give informed consent, whether a legally authorized decision-maker is involved, and whether a care partner should join the discussion.
Family history is usually central. A counselor may build a three-generation family tree, including parents, siblings, children, grandparents, aunts, uncles, and cousins. They may ask about dementia, Parkinson’s disease, ALS, psychiatric diagnoses, seizures, strokes, unusual movement symptoms, institutionalization, suicide, early deaths, and relatives who were never formally diagnosed. These questions can feel broad, but they help identify patterns that ordinary family stories may miss.
If medical records are available, they can improve accuracy. A reported “Alzheimer’s” diagnosis in a relative may have actually been frontotemporal dementia, vascular dementia, Lewy body dementia, a brain tumor, alcohol-related cognitive disorder, or another condition. When possible, records, autopsy reports, prior genetic results, or death certificates can make the genetic assessment more precise.
The counselor will also discuss who should be tested first. In many families, testing an affected person is the most informative approach. If an affected relative has a clearly disease-causing variant, then unaffected relatives can be offered targeted testing for that known variant. Testing an unaffected person first, when no family mutation has been identified, is often less informative and may produce a negative result that does not answer the family’s question.
A pretest visit should also cover practical issues, including:
- whether the test is diagnostic, predictive, or risk-based
- whether results could be uncertain
- whether the test may reveal unexpected family relationships
- how results may affect relatives
- whether insurance may cover the test
- how privacy laws apply in the person’s country or state
- whether life, disability, or long-term care insurance applications should be considered before testing
- who will receive the report
- whether results will become part of the medical record
For predictive testing, especially when someone has no symptoms but may carry a known familial variant, counseling may involve more than one visit. Some protocols include psychological assessment, a support person, waiting periods, and post-result follow-up. This is not meant to create barriers. It helps protect the person’s autonomy and reduces the chance of rushed decisions after anxiety, grief, or family pressure.
Types of Genetic Results
A genetic result is not always a simple yes or no. The main result categories are positive, negative, uncertain, and risk-related, and each one has different meaning depending on the test and the person being tested.
A positive result means the lab found a variant that is considered pathogenic or likely pathogenic. In a symptomatic person, this may confirm a genetic diagnosis or strongly support one. In an unaffected adult from a family with a known mutation, a positive predictive test may mean the person has inherited a variant associated with future disease risk. For some high-penetrance conditions, that risk may be very high, though age of onset and symptom pattern may still vary.
A negative result can mean different things. If a family has a known disease-causing variant and an at-risk relative tests negative for that exact variant, the result can be reassuring for that familial condition. But if a symptomatic person has a broad dementia panel and no variant is found, the result does not always rule out a genetic contribution. The condition may be caused by a gene not included on the panel, a variant current science cannot interpret, a non-genetic cause, or a combination of risk factors.
A variant of uncertain significance, often called a VUS, means a DNA change was found but there is not enough evidence to classify it as harmful or harmless. A VUS should generally not be used as the basis for major medical decisions or predictive testing in relatives. Over time, some uncertain variants are reclassified as more data becomes available. This is one reason genetic counseling may include discussion of lab recontact policies and whether updated interpretation may be possible later.
Risk-related results are different. APOE is the clearest example in Alzheimer’s disease. Carrying one or two copies of APOE ε4 can increase the likelihood of Alzheimer’s disease and may influence risk discussions around some treatments, but it does not prove that a person will develop dementia. Not carrying APOE ε4 does not guarantee protection. A counselor can help put this result in context rather than treating it as destiny.
Some reports may also include incidental or secondary findings, depending on the test ordered. These are findings unrelated to the original reason for testing but potentially important for health. Before testing, the counselor should explain whether such findings are possible and whether the person can choose to receive or decline them.
The hardest part for many people is that genetic information can be precise at the DNA level but still uncertain at the life level. A result may identify a gene, yet not predict the exact age symptoms will begin. It may confirm an inherited condition, yet not provide a cure. It may reduce uncertainty for one person while creating new questions for relatives. Good post-test counseling helps translate the lab report into realistic next steps.
Family, Privacy, and Insurance Issues
Genetic results can affect relatives because biological family members may share part of the same inherited risk. Counseling helps people think through what to share, when to share it, and how to protect privacy while giving relatives useful information.
For autosomal dominant dementia conditions, a pathogenic variant in one person may mean each first-degree relative has a 50% chance of carrying the same variant. First-degree relatives include parents, siblings, and children. More distant relatives may also have risk depending on the family tree. This does not mean the person tested is responsible for everyone else’s decisions, but it does mean the result may be medically relevant beyond one individual.
Family communication can be emotionally complicated. Some relatives want every detail quickly. Others may not want to know. Some families have estrangement, adoption, donor conception, unclear parentage, or cultural concerns about inherited illness. A counselor can help draft a family letter that explains the result in plain language and tells relatives how to seek genetic counseling without forcing disclosure of every personal detail.
Testing children for adult-onset brain or dementia conditions is usually discouraged when there is no medical benefit during childhood. The reason is not that families are being kept from information. It is that the child should usually have the chance to decide as an adult whether they want predictive information about an adult-onset condition. Exceptions may exist when testing would change care during childhood, but those decisions need careful specialist guidance.
Privacy and insurance issues also deserve attention before testing. In the United States, federal law offers important protections against genetic discrimination in health insurance and employment, but it does not cover every situation. Life insurance, disability insurance, and long-term care insurance may be handled differently, and rules can vary by state or country. A counselor cannot give legal advice unless qualified to do so, but they can flag the issue so a person can seek appropriate guidance before testing.
Direct-to-consumer testing adds another layer. At-home genetic reports may include APOE status or raw DNA data, but the result may not be clinically confirmed, complete, or interpreted in the context of symptoms and family history. A person should not make major medical decisions from a consumer report alone. Clinical confirmation through a certified laboratory may be needed, especially if the result could affect treatment, diagnosis, or relatives.
Emotional privacy matters too. Some people want results in the medical record because it supports care coordination. Others worry about who can access the information. Some want a spouse or adult child present for disclosure; others prefer to hear the result alone first. These preferences should be discussed before the test is ordered, not after the report arrives.
How Testing Fits the Dementia Workup
Genetic testing is only one part of a brain or dementia evaluation, and it usually does not replace cognitive testing, neurological examination, imaging, or biomarker assessment. The most useful approach is to match each test to the clinical question.
A dementia workup often begins with a careful history, medication review, neurological exam, cognitive screening, and labs that can identify treatable contributors. Depending on the symptoms, doctors may order brain MRI or CT, formal cognitive testing, sleep evaluation, or biomarkers. Genetic counseling enters the picture when the pattern suggests inherited disease or when a genetic result could affect decision-making.
For example, a person with gradual memory loss in their late 80s and no family history may need a standard Alzheimer’s diagnostic workup, not genetic testing. A person with progressive behavioral changes in their 50s and several relatives with dementia or ALS may need both neurological evaluation and genetic counseling. A person considering certain Alzheimer’s medications may discuss APOE testing as part of a treatment risk conversation, after Alzheimer’s pathology has been established.
Biomarker tests answer different questions from genetic tests. Amyloid and tau tests look for biological signs associated with Alzheimer’s disease. These may include cerebrospinal fluid testing, PET imaging, or newer blood-based tests. A genetic test looks for inherited or risk-related DNA variants. A person can have an Alzheimer’s biomarker profile without a single-gene Alzheimer’s mutation, and a person can carry a risk gene without currently having Alzheimer’s disease. When biomarker testing is being considered, it may help to understand how blood biomarker tests for Alzheimer’s disease differ from DNA-based testing.
Cognitive testing also has a separate role. It measures memory, attention, language, executive function, visuospatial skills, and other abilities. It can show the pattern and severity of impairment but usually does not identify a genetic cause by itself. In complex cases, neuropsychological testing for dementia and memory loss can help clarify whether symptoms fit Alzheimer’s disease, frontotemporal dementia, depression-related cognitive symptoms, sleep-related impairment, or another pattern.
Genetic counseling should not delay urgent medical care. Sudden confusion, new weakness on one side, trouble speaking, seizure, severe sudden headache, head injury, rapidly worsening mental status, suicidal thoughts, or dangerous behavior needs prompt medical evaluation. Those situations are not genetic counseling appointments; they are urgent clinical problems. People unsure about emergency warning signs may need guidance on urgent neurological or mental health symptoms.
The best use of genetic testing is targeted and deliberate. It should answer a real clinical or family question, not simply add another result to an already confusing pile of tests.
Questions to Ask Before Deciding
The best preparation is to ask what decision the genetic test is meant to support. If the answer is unclear, more counseling or more clinical evaluation may be needed before testing.
A person considering genetic testing may want to bring a trusted support person, a written family history, prior test results, and a list of questions. For someone with cognitive symptoms, having a care partner present can help with recall and planning. For predictive testing, a support person can also help the individual think through how they may feel before and after disclosure.
Useful questions include:
- What condition or gene are we testing for?
A clear test target helps avoid broad testing that may create uncertainty without improving care. - Is this test diagnostic, predictive, or risk-based?
The meaning of a result depends heavily on which category the test falls into. - Would a positive result change medical care?
It may affect diagnosis, treatment discussions, trial eligibility, reproductive planning, or testing for relatives. - Would a negative result actually answer the question?
In some situations, a negative result is reassuring. In others, it leaves substantial residual uncertainty. - Could the result be uncertain?
Ask how often variants of uncertain significance occur with the proposed test and how they are handled. - Should an affected relative be tested first?
Testing the right person can make the result much more informative for the whole family. - Who will receive the result?
Clarify whether it goes into the medical record, who can access it, and whether relatives receive separate documentation. - What are the privacy and insurance implications?
Ask about health insurance, employment protections, and areas that may not be covered by the same rules. - What support is available after results?
Post-test counseling, neurology follow-up, mental health support, family letters, and patient advocacy resources may all be useful. - Can I choose not to test?
Declining or delaying genetic testing can be a valid decision, especially if the result would not change care or if the person is not ready.
A thoughtful decision does not always lead to testing. Sometimes the next step is gathering records, confirming a relative’s diagnosis, completing a dementia evaluation, or waiting until a person feels ready. Sometimes testing is clearly useful and provides a long-sought answer. Either way, genetic counseling helps make the decision intentional rather than reactive.
For many families, the most valuable part of counseling is not the lab result itself. It is understanding what kind of information is being sought, what choices are available, and how to handle the result in a way that respects both the individual and the family.
References
- Alzheimer Disease Overview 2018 (GeneReviews)
- Clinical Genetic Testing for Alzheimer Disease and Related Dementias 2024 (Review)
- Lecanemab Therapy and APOE Genotype 2024 (Medical Genetics Summary)
- Human Genetics Society of Australasia Position Statement: Predictive and Presymptomatic Genetic Testing in Adults and Children 2024 (Position Statement)
- Genetic Testing of Minors for Adult-Onset Conditions 2025 (Position Statement)
- Consumer-Initiated Genetic Testing Position Statement 2025 (Position Statement)
Disclaimer
This content is for general educational purposes only and is not a substitute for medical advice, diagnosis, genetic counseling, or treatment from a qualified clinician. Decisions about dementia testing, APOE testing, predictive genetic testing, or testing relatives should be made with a healthcare professional who can review the person’s symptoms, family history, capacity to consent, and local privacy or insurance considerations.
Please share this article on Facebook, X (formerly Twitter), or your preferred platform to help others understand what genetic counseling can and cannot do before brain or dementia testing.
